Keyphrases
Failed Repair
100%
Clear Cell Renal Cell Carcinoma (ccRCC)
100%
Nucleotide Excision Repair
100%
Therapeutic Vulnerabilities
100%
Irofulven
36%
Mutational Signatures
27%
Renal Carcinoma Cells
27%
Prostaglandin Reductase
27%
Functional Assay
18%
Carcinoma Cell Lines
18%
ERCC2
18%
Tumor
9%
Bladder Cancer
9%
Cancer Types
9%
Research Biopsy
9%
Aberrations
9%
Pyrimidine
9%
UV-induced
9%
Sequence Data
9%
Anticancer Agents
9%
Next-generation Sequencing Data
9%
DNA Repair Pathways
9%
Whole Exome Sequencing
9%
Synthetic Lethality
9%
Line-based
9%
DNA Repair Deficiency
9%
Photoproducts
9%
Pyrimidone
9%
Cancer Therapeutic Agents
9%
Experimental Cancer Therapeutics
9%
Medicine and Dentistry
Clear Cell Renal Cell Carcinoma
100%
Base Excision Repair
100%
Irofulven
36%
Prostaglandin
27%
Oxidoreductase
27%
Cell Line
18%
DNA Repair
18%
Renal Cell Carcinoma Cell Line
18%
Biopsy
9%
Neoplasm
9%
Bladder Cancer
9%
Cancer Types
9%
Therapeutic Agent
9%
Target Cell
9%
Anticarcinogen
9%
Lethality
9%
Carcinoma Cell
9%
Next Generation Sequencing
9%
Exome Sequencing
9%
Experimental Neoplasm
9%
The Cancer Genome Atlas
9%
Biochemistry, Genetics and Molecular Biology
Base Excision Repair
100%
Nucleotide Excision Repair
100%
Prostaglandin
27%
Oxidoreductase
27%
Reductase
27%
DNA Repair
18%
ERCC2
18%
Transcription
9%
Target Cell
9%
Anticancer
9%
Exome Sequencing
9%
Next Generation Sequencing
9%
Immunology and Microbiology
Excision Repair
100%
Carcinoma Cell
100%
Prostaglandin
27%
Cell Line
18%
DNA Repair
18%
Renal Cell Carcinoma Cell Line
18%
Target Cell
9%
Next Generation Sequencing
9%
Whole Exome Sequencing
9%